News

3D Covid-19 Delta Variant Binds with ACE2 Receptor

Genetic mutation linked to higher SARS-CoV-2 risk

UC Riverside-led research has therapeutic implications for COVID-19 treatment
By Iqbal Pittalwala | | Health
A person's arm is shown getting the vaccine

New vaccine design uses immunity against influenza to offer faster protection against emerging pathogens

Strategy developed by UC Riverside-led research team speeds up production of antibodies against COVID-19
By Iqbal Pittalwala | | Health
Mink

Findings challenge standard understanding of COVID-19 infection

UC Riverside research can help scientists develop methods to prevent COVID-19 in mink and other species
By Iqbal Pittalwala | | Science / Technology
covid-19 virus

UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
By Iqbal Pittalwala | | Health

A potential antiviral for SARS and SARS-like coronaviruses

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
By Iqbal Pittalwala | | Health

Researchers develop molecular traps to target SARS-CoV-2

Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
By Iqbal Pittalwala | | Health